Hall R B, Robinson L H, Malawar M M, Dunham W K
Cancer. 1985 Jan 1;55(1):165-71. doi: 10.1002/1097-0142(19850101)55:1<165::aid-cncr2820550126>3.0.co;2-a.
An analysis of 6 patients with periosteal osteosarcoma treated by the authors along with a review of 55 patients reported in the literature demonstrates that periosteal osteosarcoma is distinctly different from conventional osteosarcoma or periosteal chondrosarcoma. Periosteal osteosarcoma is a less aggressive tumor than conventional osteosarcoma. It is a relatively well-differentiated chondroblastic osteosarcoma occurring on the surface of the long bones of the extremities. Three patients demonstrated frank medullary invasion of tumor, two grossly and one microsurgically. Patients treated with marginal resection had a 70% local recurrence rate. Patients receiving wide resection or primary amputation have survived longer with less recurrence of disease. Overall, 10 of 61 patients are dead with metastatic disease with a mean reported follow-up of 6 years and 7 months. Adjunctive therapy has been of no demonstrable aid in terms of prolonging survival. Medullary extension of this tumor should not be used to exclude this diagnosis. The authors believe that the treatment of choice is wide resection without adjunctive chemotherapy.
作者对6例骨膜骨肉瘤患者的分析以及对文献报道的55例患者的回顾表明,骨膜骨肉瘤与传统骨肉瘤或骨膜软骨肉瘤明显不同。骨膜骨肉瘤是一种比传统骨肉瘤侵袭性小的肿瘤。它是一种发生在四肢长骨表面的分化相对良好的软骨母细胞性骨肉瘤。3例患者显示肿瘤有明显的髓腔侵犯,2例肉眼可见,1例为显微手术所见。接受边缘切除的患者局部复发率为70%。接受广泛切除或一期截肢的患者存活时间更长,疾病复发较少。总体而言,61例患者中有10例死于转移性疾病,平均报告随访时间为6年7个月。辅助治疗在延长生存期方面没有明显帮助。该肿瘤的髓腔扩展不应作为排除该诊断的依据。作者认为,首选的治疗方法是广泛切除,不进行辅助化疗。